Beinhardt S, et al. - The physicians evaluated the safety and long-term efficacy of ribavirin (RBV)-free DAA-combinations in hepatitis C (HCV)-recurrent patients after orthothopic liver transplantation (OLT). For the treatment of HCV-recurrence after OLT, RBV-free DAA-combinations were highly efficacious and well tolerated. This long-term data demonstrated that viral eradication was durable but not necessarily translated into the beneficial long-term clinical outcome.